PGI25 Cost-Utility Analysis of Telaprevir in Combination With Peginterferon Alpha and Ribavirin in Previously Treated Patients With Chronic Hepatitis C
Abstract
Authors
M. Lukac J. Bielik J. Holoman D. Tomek A. Suvadova T. Foltanova V. Foltan